secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2023-12-20T23:59:59+00:00
Accession:  0001213900-23-097100
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jasper Therapeutics stockholders approve reverse stock split authorization up to 1-for-10
--------------------------------------------------------------------------------

- Reverse split proposal approved with 91,108,798 votes for, 873,917 against, 32,292 abstentions.
- Board may implement split at ratio between 1-for-3 and 1-for-10 at any time before Dec 15, 2024.
- Adjournment proposal also approved but was not needed; 91,306,235 votes for, 669,886 against.
- Approximately 82% of outstanding shares were represented at the Dec 15 special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390023097100/0001213900-23-097100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390023097100/ea190382-8k_jasper.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-097100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer